Literature DB >> 12782030

Nonradiometric HPLC measurement of 13(S)-hydroxyoctadecadienoic acid from rat tissues.

H Cho1, D D Gallaher, A Saari Csallany.   

Abstract

A major bioactive metabolite of linoleic acid formed by the action of 15-lipoxygenase-1 is 13(S)-hydroxy-cis-9, trans-11-octadecadienoic acid (13(S)-HODE). 13(S)-HODE is an important intracellular signal agent and is involved in cell proliferation and differentiation in various biological systems. Separation and quantification of 13(S)-HODE from biological materials has previously been achieved only by using radiolabeled linoleic acid as the substrate and two serially connected or two separate HPLC columns to achieve separation of 13(S)-HODE. In the current method, separation and quantification of 13(S)-HODE was achieved by use of a normal-phase HPLC and a solvent system containing hexane/isopropanol/acetonitrile/acetic acid (800/8/30/1, v/v) using isocratic elution with detection at 235 nm. With the currently described method, good separation from unreacted interfering compounds and quantification for 13(S)-HODE were achieved within 35 min with a minimum detection limit of 0.5 ng per injection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782030     DOI: 10.1016/s0003-2697(03)00140-4

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Multi-Biomarkers for Early Detection of Type 2 Diabetes, Including 10- and 12-(Z,E)-Hydroxyoctadecadienoic Acids, Insulin, Leptin, and Adiponectin.

Authors:  Aya Umeno; Kohzoh Yoshino; Yoshiko Hashimoto; Mototada Shichiri; Masatoshi Kataoka; Yasukazu Yoshida
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

2.  Singlet oxygen induced products of linoleates, 10- and 12-(Z,E)-hydroxyoctadecadienoic acids (HODE), can be potential biomarkers for early detection of type 2 diabetes.

Authors:  Aya Umeno; Mototada Shichiri; Noriko Ishida; Yoshiko Hashimoto; Kaori Abe; Masatoshi Kataoka; Kohzoh Yoshino; Yoshihisa Hagihara; Nanako Aki; Makoto Funaki; Yasuhiko Asada; Yasukazu Yoshida
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.